Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2008
06/19/2008CA2673108A1 Constrained spirocyclic compounds as cgrp receptor antagonists
06/19/2008CA2673097A1 Fused heterocyclic compound
06/19/2008CA2673065A1 Novel aminoguanidines as melanocortin receptor ligands
06/19/2008CA2672738A1 Treatment of pervasive developmental disorders
06/19/2008CA2672644A1 Improved method for making analgesics
06/19/2008CA2672631A1 Benzamide derivatives as ep4 receptor agonists
06/19/2008CA2672617A1 Novel 2-imidazoles as ligands for trace amine associated receptors (taar)
06/19/2008CA2672601A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
06/19/2008CA2672596A1 Compositions and methods of using (r)-pramipexole
06/19/2008CA2672591A1 Treating agent of uropathy
06/19/2008CA2672585A1 Composition containing agaricus blazei murill
06/19/2008CA2672579A1 Renin inhibitors for the prevention and treatment of hypertension in obese patients
06/19/2008CA2672565A1 Imidazothiazole derivatives
06/19/2008CA2672524A1 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor
06/19/2008CA2672503A1 Substituted aminofuranones and their use
06/19/2008CA2672496A1 Medical implants with a combination of compounds
06/19/2008CA2672494A1 Use of d-serine derivatives for the treatment of anxiety disorders
06/19/2008CA2672464A1 Dihydrobenzofuranyl derivatives and methods of their use
06/19/2008CA2672462A1 Ampa receptor potentiators
06/19/2008CA2672367A1 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
06/19/2008CA2672347A1 Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
06/19/2008CA2672295A1 Aspartyl protease inhibitors containing a tricyclic ring system
06/19/2008CA2672293A1 Aspartyl protease inhibitors
06/19/2008CA2672261A1 Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin
06/19/2008CA2672239A1 Carboxamide derivatives as ion channel modulators
06/19/2008CA2672238A1 Aminoalcohol derivatives and their therapeutic use
06/19/2008CA2672236A1 Ion channel modulators
06/19/2008CA2672226A1 Anti-inflammatory compounds containing compositions for treatment of cancer
06/19/2008CA2672223A1 Ion channel modulators
06/19/2008CA2672220A1 Impaired wound healing compositions and treatments
06/19/2008CA2672212A1 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
06/19/2008CA2672187A1 Acetylene derivatives and their use for binding and imaging amyloid plaques
06/19/2008CA2672176A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008CA2672167A1 Dihydropyridine derivatives as useful as protein kinase inhibitors
06/19/2008CA2672157A1 Method for producing solid preparation
06/19/2008CA2672154A1 Pharmaceutical composition having improved storage stability
06/19/2008CA2672153A1 Polyphenol containing compositions
06/19/2008CA2672138A1 Non-standard amino acid conjugates of amphetamine and processes for making and using the same
06/19/2008CA2672134A1 Solid medicinal preparation containing mannitol or lactose
06/19/2008CA2672132A1 Compositions of azimilide dihydrochloride
06/19/2008CA2672101A1 Compounds and compositions as kinase inhibitors
06/19/2008CA2672055A1 Treatment of cachexia
06/19/2008CA2672044A1 Use of prodrugs of gaba analogs for treating diseases
06/19/2008CA2672041A1 Nutritional supplement composition for treatment of ocular diseases
06/19/2008CA2672013A1 Nutritional supplement composition for treatment of ocular diseases
06/19/2008CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008CA2671980A1 Quinoxaline derivatives
06/19/2008CA2671979A1 Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
06/19/2008CA2671964A1 Indolizine derivatives and the use thereof as antidiabetics
06/19/2008CA2671891A1 V3 antagonists for the treatment or prevention of chronic pain
06/19/2008CA2671883A1 Synthetic agonists of tlr9
06/19/2008CA2671845A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use
06/19/2008CA2671775A1 An article comprising prasugrel
06/19/2008CA2671683A1 Pharmaceutical compositions and their methods of use
06/19/2008CA2671569A1 Means for the treatment of acute and chronic disorders of cerebral circulation, including insult, based on hydrogenated pyrido (4, 3-b) indoles (variants), pharmacological means based thereon and method for the use thereof
06/19/2008CA2671502A1 Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
06/19/2008CA2671490A1 Acetaminophen compositions having minimized side effects including reduced hepatotoxicity
06/19/2008CA2671485A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
06/19/2008CA2671478A1 Non-nucleoside reverse transcriptase inhibitors
06/19/2008CA2671473A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases
06/19/2008CA2671460A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases
06/19/2008CA2671449A1 Composite material for tissue repair
06/19/2008CA2671336A1 Epothilone analogues modified at positions c12-c13 as anticancer drugs
06/19/2008CA2671315A1 Method of preventing or treating myocardial ischemia by inhibiting dgat1 enzyme with a dgat1 inhibitor
06/19/2008CA2671040A1 Use of pkc inhibitors in transplantation
06/19/2008CA2670728A1 Pyridine derivatives used as xiap inhibitors
06/19/2008CA2669818A1 Macrolide compounds endowed with antiinflammatory activity
06/19/2008CA2669536A1 Composition for treating a pulmonary hypertension
06/19/2008CA2669535A1 Ambrisentan combined with a renin inhibitor for hypertensive disorders
06/19/2008CA2669137A1 Long term disease modification using immunostimulatory oligonucleotides
06/19/2008CA2668576A1 Ocular devices and methods of making and using thereof
06/19/2008CA2668185A1 Processes to prepare antimicrobial contact lenses
06/19/2008CA2667069A1 Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
06/19/2008CA2658836A1 Uses of disease gene promoters for providing therapeutic cell populations
06/19/2008CA2652995A1 Novel inhibitors of beta-lactamase
06/19/2008CA2650329A1 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors
06/19/2008CA2615345A1 Crystalline form of rabeprazole sodium
06/18/2008EP1932926A2 Method of diagnosing ovarian endometriosis
06/18/2008EP1932845A1 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
06/18/2008EP1932843A1 Sulfonyl-phenyl-2H-(1,2,4) oxadiazole-5-one derivatives, processes for their preparation and their use as pharmaceuticals
06/18/2008EP1932841A1 Sulfonamide compound
06/18/2008EP1932840A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
06/18/2008EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/18/2008EP1932838A2 Beta-form crystal of acetanilide derivative
06/18/2008EP1932837A1 Bicyclo heterocyclic compound having antifungal action
06/18/2008EP1932834A1 Aromatic 1,4-DI-Carboxylamides and their use
06/18/2008EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
06/18/2008EP1932832A1 Triarylcarboxylic acid derivative
06/18/2008EP1932831A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols
06/18/2008EP1932830A1 Sulfonamides and their use as a medicament
06/18/2008EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host
06/18/2008EP1932543A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue
06/18/2008EP1932541A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent
06/18/2008EP1932530A1 Agent for enhancing collagen production and utilization of the same
06/18/2008EP1932529A1 Method of improved diuresis in individuals with impaired renal function
06/18/2008EP1932528A1 Stable composition of amlodipine besylate
06/18/2008EP1932527A1 The use of phthalide derivatives
06/18/2008EP1932526A1 Morin, a new inhibitor of microbial hyaluronate lyase
06/18/2008EP1932525A1 Skin-care preparations containing mupirocin and betamethasone dipropionate
06/18/2008EP1932524A1 Pharmaceutical preparations for treating inflammatory diseases
1 ... 3216 3217 3218 3219 3220 3221 3222 3223 3224 3225 3226 3227 3228 3229 3230 3231 3232 3233 3234 3235 3236 ... 7860